Sponsor of the Day:
Jerkmate
https://briibio.com/en/media/press-release/20220527/
Brii Biosciences Announces Upcoming Conference Participation in June | Brii Biosciences
We innovate and advance novel therapies to provide greater choice and freedom to broad patient populations. Brii Biosciences is a biotechnology company...
brii biosciencesannounces upcomingconference participationjune
https://neurosciencenews.com/cortice-bioscience-tpi-287-7871/
Cortice Biosciences Announces Presentation of Results from Placebo-Controlled Phase 1 Clinical...
Nov 4, 2017 - Cortice Biosciences announced today results from placebo-controlled, double-blinded Phase 1 studies evaluating TPI 287, a brain penetrable microtubule...
phase 1 clinicalbiosciences announcesplacebo controlledpresentationresults
https://www.biospace.com/press-releases/ideaya-biosciences-announces-first-patient-in-for-phase-1-trial-of-ide574-a-potential-first-in-class-dual-inhibitor-of-kat6-7-to-target-multiple-solid-tumor-indications-including-breast-prostate-crc-and-lung-cancer
IDEAYA Biosciences Announces First-Patient-In for Phase 1 Trial of IDE574, a Potential First-In...
biosciences announcesfirst patientphase 1ideayatrial
https://www.biospace.com/colossal-biosciences-secures-150m-series-b-and-announces-plan-to-de-extinct-the-iconic-dodo
Colossal Biosciences Secures $150M Series B and Announces Plan to De-Extinct the Iconic Dodo -...
Jan 31, 2023 - Colossal Biosciences, the world’s first de-extinction company, has today announced an oversubscribed $150M Series B financing led by United States Innovative...
colossal biosciences150m seriesannounces plande extinctsecures